1
|
Gómez-Armayones S, Chimenos-Küstner E, Arranz C, Tous S, Marquez S, Penín RM, Quirós B, Taberna M, Alemany L, Servitje O, Mena M. Response to "The significance of oral epithelial dysplasia in the clinical management of oral potentially malignant disorders". Int J Oral Maxillofac Surg 2023; 52:511. [PMID: 36058823 DOI: 10.1016/j.ijom.2022.06.023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2022] [Accepted: 06/29/2022] [Indexed: 11/15/2022]
Affiliation(s)
- S Gómez-Armayones
- Department of Dermatology, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain; Department of Dermatology, Hospital Clínic of Barcelona, Barcelona, Spain
| | - E Chimenos-Küstner
- Department of Odontostomatology, Odontological University Hospital of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain
| | - C Arranz
- Department Oral and Maxillofacial Surgery, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain
| | - S Tous
- Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain
| | - S Marquez
- Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain
| | - R-M Penín
- Department of Pathology, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain
| | - B Quirós
- Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain
| | - M Taberna
- Department of Medical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain; Program of Molecular Mechanisms and Experimental Therapy in Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain
| | - L Alemany
- Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain
| | - O Servitje
- Department of Dermatology, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain
| | - M Mena
- Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain
| |
Collapse
|
2
|
Gómez-Armayones S, Chimenos-Küstner E, Arranz C, Tous S, Marquez S, Penín RM, Quirós B, Taberna M, Alemany L, Servitje O, Mena M. Risk factors for oral epithelial dysplasias to become malignant: clinical implications. Int J Oral Maxillofac Surg 2021; 51:473-480. [PMID: 34503889 DOI: 10.1016/j.ijom.2021.08.012] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2020] [Revised: 05/23/2021] [Accepted: 08/12/2021] [Indexed: 10/20/2022]
Abstract
There is a lack of effective clinical management of oral epithelial dysplasias to reduce their risk of malignant transformation and considerable gaps in knowledge regarding the most effective means of treating such lesions. A retrospective cohort of biopsy-confirmed oral epithelial dysplasias consecutively diagnosed in the period 1995-2014 and followed-up until 2017 was identified from pathology department files. Demographic, clinical and follow-up information was collected. Multivariate Cox proportional-hazards models were performed to evaluate sociodemographic, clinical and pathological factors associated with progression to oral squamous cell carcinoma. The study included 144 oral epithelial dysplasias, of which 42% progressed to oral cancer at the end of follow-up (21 years). Clinical aspect of the lesion was described for 77 (53.5%) of the patients. Treatment, age, grade of the lesion and diagnostic period were independent prognostic factors for progression. When considering only patients with described clinical aspect, only treatment and grade of the lesion were independently associated with cancer. The results from this non-selected retrospective cohort of oral epithelial dysplasias underscore the existing limitations of the current standard-of-care of the patients and provide novel insights on the management of these lesions with and without described clinical aspect. Well-designed, robust prospective studies, a homogenized staging system and multidisciplinary treatment guidelines are warranted.
Collapse
Affiliation(s)
- S Gómez-Armayones
- Department of Dermatology, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain; Department of Dermatology, Hospital Clínic of Barcelona, Barcelona, Spain.
| | - E Chimenos-Küstner
- Department of Odontostomatology, Odontological University Hospital of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain
| | - C Arranz
- Department Oral and Maxillofacial Surgery, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain
| | - S Tous
- Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain
| | - S Marquez
- Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain
| | - R M Penín
- Department of Pathology, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain
| | - B Quirós
- Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain
| | - M Taberna
- Department of Medical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain; Program of Molecular Mechanisms and Experimental Therapy in Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain
| | - L Alemany
- Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain
| | - O Servitje
- Department of Dermatology, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain
| | - M Mena
- Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain
| |
Collapse
|
3
|
Vives-Soler A, Chimenos-Küstner E. Effect of probiotics as a complement to non-surgical periodontal therapy in chronic periodontitis: a systematic review. Med Oral Patol Oral Cir Bucal 2020; 25:e161-e167. [PMID: 31893476 PMCID: PMC7103449 DOI: 10.4317/medoral.23147] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2019] [Accepted: 12/23/2019] [Indexed: 02/06/2023] Open
Abstract
Background To improve the results of the classic periodontal treatment, probiotics have been suggested recently to decrease the number of bacteria and the expression of mediators of inflammation. This systematic review aimed to assess the literature for the effectiveness of different probiotic strains as adjuvants to non-surgical periodontal therapy.
Material and Methods The electronic database of MEDLINE (via Pubmed) was searched up to December 2017 for randomised clinical trials in English comparing non-surgical periodontal treatment and probiotics versus periodontal treatment and placebo. The primary outcome investigated was reduction in pocket probing depth. Secondary outcomes were bleeding on probing, plaque index reduction and bacteria counts.
Results Nine trials were included. A narrative data synthesis did not result in any major improvement of overall pocket probing depth but moderate pockets from 4 to 6 mm showed larger reductions in study groups, which could decrease the need for surgery. Sites with bleeding on probing and presence of plaque decreased after treatment. For periimplant mucositis, there was a small tendency to better results in the study group.
Conclusions With the available data, it is concluded that probiotics may provide an additional benefit to manual debridement in chronic periodontitis. More studies are required on dose, route of administration and strains of probiotics used. Key words:Periodontics, chronic periodontitis, probiotics, periodontal treatment, lactobacillus, streptococcus.
Collapse
Affiliation(s)
- A Vives-Soler
- C/Sabino Arana, 6, 10th floor 1st door 08028, Barcelona, Spain
| | | |
Collapse
|
4
|
Giovannoni ML, Valdivia-Gandur I, Lozano de Luaces V, Varela Véliz H, Balasubbaiah Y, Chimenos-Küstner E. Betel and tobacco chewing habit and its relation to risk factors for periodontal disease. Oral Dis 2018; 24:829-839. [DOI: 10.1111/odi.12820] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2017] [Revised: 11/24/2017] [Accepted: 12/14/2017] [Indexed: 12/27/2022]
Affiliation(s)
- ML Giovannoni
- Odontostomatology Department; Universitat de Barcelona; Barcelona Spain
| | - I Valdivia-Gandur
- Biomedical Department and Dentistry Department; Universidad de Antofagasta; Antofagasta Chile
| | - V Lozano de Luaces
- Dentistry Coordinator of Rural Development Trust; Vicente Ferrer Foundation; Barcelona Spain
| | - H Varela Véliz
- Mathematic Department; Universidad de Antofagasta; Antofagasta Chile
| | - Y Balasubbaiah
- Director of Kalyandurg Hospital-Kanekal; Anantapur India
| | | |
Collapse
|
5
|
Chimenos-Küstner E. Letter to Editor: Support to the Spanish language, from Oral Medicine. Med Oral Patol Oral Cir Bucal 2017; 22:e398-e399. [PMID: 28578376 PMCID: PMC5549511 DOI: 10.4317/medoral.21742] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2016] [Accepted: 04/26/2017] [Indexed: 11/06/2022] Open
Abstract
In the form of a letter to the director, the author provides linguistic comments related to Spanish. He draws attention to some often misused words and suggests some expressions that may improve the use of the Spanish language in scientific texts.
Key words:Spelling, linguistics, scientific language.
Collapse
Affiliation(s)
- E Chimenos-Küstner
- Department of Odontostomatology Oral Medicine, Bellvitge University Campus, Feixa Llarga s/n, 08907-Hospitalet de Llobregat, Barcelona, Spain,
| |
Collapse
|
6
|
Rodríguez de Rivera Campillo E, López-López J, Chimenos-Küstner E. Response to topical clonazepam in patients with burning mouth syndrome: a clinical study. Bull Group Int Rech Sci Stomatol Odontol 2010; 49:19-29. [PMID: 22750263] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Received: 05/21/2010] [Indexed: 06/01/2023]
Abstract
Burning Mouth Syndrome (BMS) is a difficult disease for patients and clinicians. Moreover, there is not a general consensus on how to treat the disease. The main objective of this paper is to evaluate BMS patients' response to topical clonazepam treatment. A double blind study was performed. Among a total of 66 patients, 33 were treated with tablets of clonazepam and another 33 were treated with a placebo. Symptoms were evaluated after 1 month and 6 months of treatment and scored on an analogical scale from 0 to 10. Among the 33 patients treated with clonazepam, 23 showed at least a 50% reduction in symptoms after 1 month of treatment. On the contrary, only 4 in the placebo group exhibited significant improvement. After 6 months, significant differences were observed again, as 23 of the 33 patients treated with the drug reported at least a 50% reduction in symptoms, whereas only 2 among those treated with the placebo significantly improved. However, when measured in terms of a complete cure (lack of symptoms), the differences were not significant: 5 drug-treated patients and one belonging to the placebo group were asymptomatic after one month of treatment. In summary, it seems that clonazepam applied topically was effective in treating BMS in a large proportion of patients.
Collapse
|
7
|
Abstract
Odontogenic keratocysts, characterized by considerable local aggressiveness and high recurrence rates, account for 5-15% of all odontogenic cysts. This paper reviews the literature and describes the most important aspects of this type of cyst, a clinical example being given as way of illustration. We also report a paleopathological case featuring an osteolytic lesion where the characteristics are consistent with a keratocyst. The aim is thus to encourage odontologists to contribute to research in the field of paleopathology.
Collapse
|
8
|
Chimenos-Küstner E. [Treatment of oral Candidosis]. Med Oral 2003; 8:229. [PMID: 12730660] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 03/02/2023]
Affiliation(s)
- E Chimenos-Küstner
- Medicina Bucal, Facultad de Odontología, Universidad de Barcelona, Spain
| |
Collapse
|